Transform Biomedicine and Drug Discovery Through Innovative Proteomics
Proteomics is pivotal in bridging the gap between basic biomedical research and the development of new, targeted therapeutics.
Hidden causes of diseases can be revealed by proteomics, which is instrumental in identifying new biomarkers and therapeutic targets to support drug discovery.
In this webinar, you’ll hear from Christof Lenz, PhD, about the importance of analyzing tissue samples in biomedical proteomics, particularly for understanding the molecular basis of cardiac diseases. Our second speaker, Greg Potts, PhD, will showcase how chemoproteomics, in combination with data-independent acquisition, speeds up drug discovery.
You’ll also gain insights into innovative strategies for boosting proteomic analysis through standardized sample prep technologies and state-of-the-art mass-spectrometry-based workflows.
Attend this webinar to:
- Learn how optimized proteomic sample preparation can be a game-changer in biomedical research
- Gain insights into cardiac disease mechanisms through tissue proteomics
- Explore how modern chemoproteomic approaches and MS acquisition techniques advance drug discovery
- Discover how standardized and efficient sample prep can help obtain reliable data while scaling proteome study size
Presenter: Christof Lenz, PhD (Director Core Facility Proteomics, University Medical Center Göttingen)
Presenter: Gregory Potts, PhD (Senior Scientist, Technology and Therapeutic Platforms, AbbVie)
